The loss of TET2 catalytic activity in older animals resulted in an increased percentage of monocytes and a decreased percentage of granulocytes and B cells, suggesting that the acquisition of aging-mediated abnormal transcription programs promotes the transformation of TET2 mutation-associated myeloid tumors. This evidence concerns the gene TET2 and myeloid neoplasm.